Our previous studies have demonstrated that CFTR acts as a tumor/EMT suppressor, which is shown to be downregulated and associated with poor prognosis in prostate cancer [16], breast cancer [26], colon cancer [29] and lung cancer [30]. This evidence concerns the gene CFTR and neoplasm.